• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Immunogenicity of SARS-CoV-2 BNT162b2 vaccine in solid organ transplant recipients.

作者信息

Marinaki Smaragdi, Adamopoulos Stamatis, Degiannis Dimitrios, Roussos Sotirios, Pavlopoulou Ioanna D, Hatzakis Angelos, Boletis Ioannis N

机构信息

Clinic of Nephrology and Renal Transplantation NKUA, Medical School, Laiko General Hospital, Athens, Greece.

Heart Failure and Transplant Units, Onassis Cardiac Surgery Center, Athens, Greece.

出版信息

Am J Transplant. 2021 Aug;21(8):2913-2915. doi: 10.1111/ajt.16607. Epub 2021 May 7.

DOI:10.1111/ajt.16607
PMID:33864722
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8250574/
Abstract
摘要

相似文献

1
Immunogenicity of SARS-CoV-2 BNT162b2 vaccine in solid organ transplant recipients.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）BNT162b2疫苗在实体器官移植受者中的免疫原性。
Am J Transplant. 2021 Aug;21(8):2913-2915. doi: 10.1111/ajt.16607. Epub 2021 May 7.
2
Serological response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients depends on prior exposure to SARS-CoV-2.肾移植受者对新型冠状病毒mRNA疫苗BNT162b2的血清学反应取决于既往对新型冠状病毒的接触情况。
Am J Transplant. 2021 Nov;21(11):3806-3807. doi: 10.1111/ajt.16726. Epub 2021 Jul 10.
3
SARS-CoV-2 vaccine effectiveness trumps immunogenicity in solid organ transplant recipients.严重急性呼吸综合征冠状病毒2型（SARS-CoV-2）疫苗对实体器官移植受者的有效性优于免疫原性。
Am J Transplant. 2021 Dec;21(12):4105. doi: 10.1111/ajt.16744. Epub 2021 Jul 16.
4
Comparison of mRNA-1273 and BNT162b2 SARS-CoV-2 mRNA Vaccine Immunogenicity in Kidney Transplant Recipients.肾移植受者中mRNA-1273和BNT162b2新冠病毒mRNA疫苗免疫原性的比较
Transpl Int. 2022 Jan 4;35:10026. doi: 10.3389/ti.2021.10026. eCollection 2021.
5
A Pilot Single-Blinded, Randomized, Controlled Trial Comparing BNT162b2 vs. JNJ-78436735 Vaccine as the Third Dose After Two Doses of BNT162b2 Vaccine in Solid Organ Transplant Recipients.一项比较 BNT162b2 与 JNJ-78436735 疫苗作为两剂 BNT162b2 疫苗后第三剂在实体器官移植受者中应用的单盲、随机、对照试验的初步研究。
Transpl Int. 2023 Apr 5;36:10938. doi: 10.3389/ti.2023.10938. eCollection 2023.
6
Interpreting and addressing suboptimal immune responses after COVID-19 vaccination in solid-organ transplant recipients.解读和应对实体器官移植受者 COVID-19 疫苗接种后免疫应答不佳的问题。
J Clin Invest. 2021 Jul 15;131(14). doi: 10.1172/JCI151178.
7
Reduced humoral response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus: Not alarming, but should be taken gravely.未接触过病毒的肾移植受者对SARS-CoV-2 mRNA疫苗BNT162b2的体液反应降低：虽不令人恐慌，但应予以高度重视。
Am J Transplant. 2021 Aug;21(8):2909. doi: 10.1111/ajt.16710. Epub 2021 Jun 18.
8
Update on COVID-19 vaccination in pediatric solid organ transplant recipients.儿童实体器官移植受者 COVID-19 疫苗接种的最新进展。
Pediatr Transplant. 2022 Aug;26(5):e14235. doi: 10.1111/petr.14235. Epub 2022 Jan 20.
9
Differences in Antibody Responses Between an Inactivated SARS-CoV-2 Vaccine and the BNT162b2 mRNA Vaccine in Solid-Organ Transplant Recipients.实体器官移植受者中灭活 SARS-CoV-2 疫苗和 BNT162b2 mRNA 疫苗的抗体反应差异。
Exp Clin Transplant. 2021 Dec;19(12):1334-1340. doi: 10.6002/ect.2021.0402.
10
Effectiveness of first, second, and third COVID-19 vaccine doses in solid organ transplant recipients: A population-based cohort study from Canada.COVID-19 疫苗在实体器官移植受者中的首剂、二剂和三剂的有效性：来自加拿大的一项基于人群的队列研究。
Am J Transplant. 2022 Sep;22(9):2228-2236. doi: 10.1111/ajt.17095. Epub 2022 Jun 1.

引用本文的文献

1
COVID-19's impact on heart and lung transplantation: Citation-based analysis of research output.新冠病毒病对心脏和肺移植的影响：基于文献引用的研究产出分析
World J Transplant. 2025 Jun 18;15(2):99992. doi: 10.5500/wjt.v15.i2.99992.
2
Long-term immune response after SARS-CoV2 vaccination in solid organ transplant recipients.实体器官移植受者接种新冠病毒疫苗后的长期免疫反应。
BMC Infect Dis. 2025 Apr 25;25(1):606. doi: 10.1186/s12879-024-10377-1.
3
Immunogenicity and Predictive Factors Associated with Poor Response after Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination in Lung Transplant Patients.严重急性呼吸综合征冠状病毒2疫苗接种后肺移植患者免疫原性及与反应不佳相关的预测因素
Vaccines (Basel). 2024 Jul 22;12(7):822. doi: 10.3390/vaccines12070822.
4
Incidence and Severity of COVID-19 in Relation to Anti-Receptor-Binding Domain IgG Antibody Level after COVID-19 Vaccination in Kidney Transplant Recipients.肾移植受者 COVID-19 疫苗接种后抗受体结合域 IgG 抗体水平与 COVID-19 发病和严重程度的关系。
Viruses. 2024 Jan 12;16(1):114. doi: 10.3390/v16010114.
5
Clinical Utility of SARS-CoV-2 Serological Testing and Defining a Correlate of Protection.新型冠状病毒2型血清学检测的临床应用及确定保护相关性
Vaccines (Basel). 2023 Oct 26;11(11):1644. doi: 10.3390/vaccines11111644.
6
Low switched memory B cells are associated with no humoral response after SARS-CoV-2 vaccine boosters in kidney transplant recipients.低转换记忆 B 细胞与肾移植受者接种 SARS-CoV-2 疫苗加强针后无体液免疫反应相关。
Front Immunol. 2023 Oct 24;14:1202630. doi: 10.3389/fimmu.2023.1202630. eCollection 2023.
7
Weaker SARS-CoV-2 vaccine responses in nonalcoholic fatty liver disease with advanced liver fibrosis.非酒精性脂肪性肝病合并晚期肝纤维化患者对SARS-CoV-2疫苗的反应较弱。
Vaccine X. 2023 Oct 12;15:100359. doi: 10.1016/j.jvacx.2023.100359. eCollection 2023 Dec.
8
Hybrid Immunity Provides the Best COVID-19 Humoral Response in Immunocompromised Patients with or without SARS-CoV-2 Infection History.混合免疫在有或无SARS-CoV-2感染史的免疫功能低下患者中提供最佳的新冠病毒体液反应。
Vaccines (Basel). 2023 Aug 18;11(8):1380. doi: 10.3390/vaccines11081380.
9
Delayed and Attenuated Antibody Responses to Coronavirus Disease 2019 Vaccination With Poor Cross-Variant Neutralization in Solid-Organ Transplant Recipients-A Prospective Longitudinal Study.实体器官移植受者中2019冠状病毒病疫苗接种的抗体反应延迟且减弱，交叉变异中和能力差——一项前瞻性纵向研究
Open Forum Infect Dis. 2023 Aug 10;10(8):ofad369. doi: 10.1093/ofid/ofad369. eCollection 2023 Aug.
10
Humoral and Cellular Immunity following Five Doses of COVID-19 Vaccines in Solid Organ Transplant Recipients: A Systematic Review and Meta-Analysis.实体器官移植受者接种五剂新冠疫苗后的体液免疫和细胞免疫：一项系统评价和荟萃分析
Vaccines (Basel). 2023 Jun 27;11(7):1166. doi: 10.3390/vaccines11071166.

本文引用的文献

1
Anti-Spike Protein Assays to Determine SARS-CoV-2 Antibody Levels: a Head-to-Head Comparison of Five Quantitative Assays.抗刺突蛋白检测法用于测定 SARS-CoV-2 抗体水平：五种定量检测方法的头对头比较。
Microbiol Spectr. 2021 Sep 3;9(1):e0024721. doi: 10.1128/Spectrum.00247-21. Epub 2021 Jun 30.
2
Immunogenicity of a Single Dose of SARS-CoV-2 Messenger RNA Vaccine in Solid Organ Transplant Recipients.mRNA 疫苗在实体器官移植受者中的单剂免疫原性。
JAMA. 2021 May 4;325(17):1784-1786. doi: 10.1001/jama.2021.4385.
3
Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates.两种基于 RNA 的新冠候选疫苗的安全性和免疫原性。
N Engl J Med. 2020 Dec 17;383(25):2439-2450. doi: 10.1056/NEJMoa2027906. Epub 2020 Oct 14.
4
Factors associated with COVID-19-related death using OpenSAFELY.使用 OpenSAFELY 分析与 COVID-19 相关死亡的因素。
Nature. 2020 Aug;584(7821):430-436. doi: 10.1038/s41586-020-2521-4. Epub 2020 Jul 8.
5
Influenza vaccination in the organ transplant recipient: review and summary recommendations.器官移植受者的流感疫苗接种：综述和总结建议。
Am J Transplant. 2011 Oct;11(10):2020-30. doi: 10.1111/j.1600-6143.2011.03753.x.